1. Abeliovich, D., Lavon, I. P., Lerer, I., Cohen, T., Springer, C., Avital, A., and Cutting, G., 1992, Screening for five mutations detects 97% of cystic fibrosis (of) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population, Am. J. Hum. Genet. 51:951–956.
2. Aitken, M. L., 1993, Clinical trials of recombinant human in cystic fibrosis patients, Monaldi Arch. Chest. Dis. 48:653–656.
3. Aitken, M. L., Burke, W., McDonald, G., Shak, S., Montgomery, A. B., and Smith, A., 1992, Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study, JAMA 267:1947–1951.
4. Anderson, M. P., Rich, D. P., Gregory, R. J., Smith, A. E., and Welsh, M. J., 1991, Generation of c-AMP-activated chloride currents by expression of CFTR, Science 251:679–682.
5. Armstrong, J. B., and White, J. C., 1950, Liquefaction of viscous purulent exudates by deoxyribonuclease, Lancet 2:739–740.